March 25, 2020 Atomic Spectroscopy Lab Top-10 Product Launch

Italian Researchers Identify New SARS-CoV-2 Gene Variants That Provide Clues to Coronavirus's Epidemiology

Italian Researchers Identify New SARS-CoV-2 Gene Variants That Provide Clues to Coronavirus’s Epidemiology Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development CARLSBAD, Calif., March 25, 2020 /PRNewswire/ — Two teams of infectious disease researchers in Italy... Read more

March 24, 2020 Acad, Gov/Utilities Lab Top-10 PAI Top-10

FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing

WALTHAM, Mass.–(BUSINESS WIRE)–Mar. 24, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company’s New Coronavirus RT-PCR test. Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using... Read more

March 24, 2020 Lab Top-10

Bruker Announces Launch of CE-IVD Marked genesig® Assay Kit for the Detection of the SARS-CoV-2 Virus

Real-Time PCR kit validated for a variety of respiratory samples types Validated with Bruker-Hain GenoXtract 12 DNA/ RNA extraction system and kits Agreement signed with Primer Design LTD (UK), part of the Novacyt Group, for Bruker-Hain Diagnostics distribution of CE-IVD marked genesig® COVID-19 diagnostics kits NEHREN, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced a... Read more

March 23, 2020 Lab Top-10

Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes

WALTHAM, Mass., March 23, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher“) announced today that it has priced an offering of $2.2 billion aggregate principal amount (the “Offering”) of the following notes: $1.1 billion aggregate principal amount of its 4.133% senior notes due 2025, at the issue price of 100% of their principal... Read more

March 23, 2020 Bio/Pharma/CRO Lab Top-10 Licensing, IP, and Legal PR/Corporate

Thermo Fisher Scientific Continues Investments to Accelerate Biopharma Commercialization

Thermo Fisher Scientific Continues Investments to Accelerate Biopharma Commercialization Capabilities and capacity now available to help customers of all sizes meet increasing demand for new biologics, cell and gene therapies, and drug products NEEDHAM, Mass., March 23, 2020 /PRNewswire/ — For biopharma companies faced with increasing demand for new biologics, cell and gene therapies, and drug... Read more

March 19, 2020 Bio/Pharma/CRO Environ, Ag./Food & Bev Lab Top-10 PR/Corporate

Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences

Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences WASHINGTON, March 19, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that the U.S. Federal Trade Commission (the “FTC”) has accepted the proposed consent order in connection with Danaher’s definitive agreement with General... Read more

March 16, 2020 Clinical Research/Diagn. Lab Top-10 Product Launch

New Thermo Scientific Cascadion SM Clinical Analyzer with 25-Hydroxy Vitamin D Assay Available in the U.S.

New Thermo Scientific Cascadion SM Clinical Analyzer with 25-Hydroxy Vitamin D Assay Available in the U.S. VANTAA, Finland, March 16, 2020 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced that its Thermo Scientific Cascadion SM Clinical Analyzer is now commercially available in the U.S. with the Cascadion SM 25-Hydroxy Vitamin D... Read more

March 14, 2020 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10

FDA Issues Emergency Use Authorization to Thermo Fisher Scientific for Diagnostic Test Used to Detect COVID-19

FDA Issues Emergency Use Authorization to Thermo Fisher Scientific for Diagnostic Test Used to Detect COVID-19 WALTHAM, Mass., March 13, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for its diagnostic test that... Read more

March 12, 2020 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Signs Agreement with Janssen to Co-Develop Companion Diagnostic for Cancer

Thermo Fisher Scientific Signs Agreement with Janssen to Co-Develop Companion Diagnostic for Cancer CARLSBAD, Calif., March 12, 2020 /PRNewswire/ — Thermo Fisher Scientific announced today it has signed an agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to co-develop a companion diagnostic (CDx) in oncology. The CDx will... Read more